Implication of Altered Redox Regulation by Antioxidant Enzymes in the Increased Plasma Pentosidine, an Advanced Glycation End Product, in Uremia
- 28 April 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 245 (3) , 785-790
- https://doi.org/10.1006/bbrc.1998.8523
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Advanced Glycation Endproducts Stimulate Mitogen-Activated Protein Kinase and Proliferation in Rabbit Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1997
- Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapyKidney International, 1997
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- Erythrocyte Redox State in Uremic Anemia: Effects of Hemodialysis and Relevance of Glutathione MetabolismActa Haematologica, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993
- Increased Lipid Peroxidation in Patients on Maintenance HemodialysisNephron, 1992
- Hydrogen peroxide production during experimental protein glycationFEBS Letters, 1990
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988